Trial Profile
Prospective study of sarpogrelate versus clopidogrel-based dual antiplatelet therapies in patients undergoing femoropopliteal arterial endovascular interventions
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2016
Price :
$35
*
At a glance
- Drugs Sarpogrelate (Primary) ; Aspirin; Clopidogrel
- Indications Arterial occlusive disorders
- Focus Adverse reactions
- 04 Apr 2016 New trial record